GH - Guardant Health, Inc.

QQQ $ 427.02 $ 1.78 (0.42 %)

DIA $ 382.31 $ 3.42 (0.9 %)

SPY $ 505.01 $ 0.61 (0.12 %)

TLT $ 88.87 $ 0.31 (0.35 %)

GLD $ 213.12 $ -0.67 (-0.31 %)

Previous Close

$ 18.26

Open

$ 18.56

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 18.00 - $ 18.67

52 Week Range

$ 15.81 - $ 41.06

Volume

1,159,567

Average Volume

Market Cap

2.04B

Beta (5Y Monthly)

$ 1.16

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-22-2024	12-31-2023	10-K
2	11-06-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-23-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-24-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	03-02-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-10-2019	03-31-2019	10-Q
21	03-19-2019	12-31-2018	10-K
22	11-19-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Guardan...
04/29/2024 14:37:52

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $45 ...

Key Takeaways From Guardant Health Analyst...
04/24/2024 18:01:21

Craig-Hallum Assumes Guardant Health at Bu...
04/24/2024 17:34:12

Craig-Hallum analyst Alex Nowark assumes Guardant Health (NASDAQ:GH) with a Buy rating and announces Price Target of $28.

matterport-sea-limited-ingevity-and-other-big-stocks-moving-higher-on-monday

Matterport, Sea Limited, Ingevity And Othe...
04/22/2024 14:10:39

Goldman Sachs Maintains Buy on Guardant He...
04/15/2024 14:25:53

Goldman Sachs analyst Matthew Sykes maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $32 to...

Analyst Expectations For Guardant Health's...
04/05/2024 15:00:37

Guggenheim Reiterates Neutral on Guardant ...
04/05/2024 14:06:29

Guggenheim analyst Subbu Nambi reiterates Guardant Health (NASDAQ:GH) with a Neutral.

rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

REX American Resources Reports Upbeat Earn...
03/28/2024 15:00:16

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

Insiders Buying Advance Auto Parts And 2 O...
03/20/2024 13:02:44

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

Guardant Health Says ECLIPSE Study Data De...
03/13/2024 21:01:17

Guardant Health Says New Survey Shows Pati...
03/01/2024 10:37:44

cancer-test-focused-guardant-health-stock-falls-on-fda-adcom-update-for-colorectal-test

Cancer Test Focused Guardant Health Stock ...
02/23/2024 18:35:35

Guardant Health surpasses Q4 2023 revenue expectations, reporting $155.1 million. Precision oncology revenue is up 25% to $142....

4 Analysts Have This To Say About Guardant...
02/23/2024 18:01:05

Canaccord Genuity Maintains Buy on Guardan...
02/23/2024 14:42:45

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $50 ...

Guardant Health Expects Full Year 2024 Rev...
02/22/2024 21:31:33

Guardant Health: Q4 Earnings Insights
02/22/2024 21:10:30

Guardant Health Q4 Adj EPS $(0.64) Beats $...
02/22/2024 21:09:44

Guardant Health (NASDAQ:GH) reported quarterly Adj losses of $(0.64) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Decoding 4 Analyst Evaluations For Guardan...
01/30/2024 17:01:02

Goldman Sachs Maintains Buy on Guardant He...
01/30/2024 13:58:33

Goldman Sachs analyst Matthew Sykes maintains Guardant Health (NASDAQ:GH) with a Buy and lowers the price target from $43 to...